The risk now is that AstraZeneca does not want anyone. The new EMA assessment, which has established the inoculation of the Anglo-Swedish vaccine only from the age of 60 onwards, risks creating serious problems in vaccination campaigns. Especially in the South and in Puglia, where even before the new turnaround of the European drug agency, AstraZeneca was seen as a series B vaccine, possibly to be avoided.
AstraZeneca, Ministry of Health: recommended for use over 60. Second dose with the same vaccine
The governor has centered on the theme that will arise in the coming days Michele Emiliano: “About one in two doses of AstraZeneca is rejected by us. With this confused way of communicating the EMA, it will get worse and worse ”he declared in the last meeting between the presidents of the Region, the government and the extraordinary commissioner for the Coronavirus emergency.
Vaccines, 34 million doses need to be replaced in the new plan
by Giuliano Foschini, Fabio Tonacci
Rejection of the Oxford vaccine was already very strong in Puglia, especially in the younger population group. This is what the regional health councilor confirms, Pierluigi Lopalco: “We do not have precise data, but last Sunday on the last day of vaccination of the caregivers, therefore an average young segment of the population, we had clinics in which peaks of 40 per cent of waste were reached”. So now the risk is that that percentage could rise to the top. “It is obvious that when we go to propose this vaccine today – explains Lopalco – it will take twice as long to explain what happened and that there are no safety problems. So an exceptional commitment will be needed on the part of the doctors who will take longer to vaccinate ”.
Vaccines, AstraZeneca in Italy for over 60s. Ema: it can cause rare thrombosis
by Tommaso Ciriaco, Alberto D’Argenio
The point is that even in the Region the worst is now feared: “When there should be difficulties in getting this vaccine accepted, we would find a very important birth cohort in the vaccination campaign, such as that of the over 70s, with low coverage. The government has pledged to launch a communication campaign. But I am afraid that the omelette has been made. People now need to understand that in such a situation with low vaccine availability you can’t make vaccine choice as if you were in the supermarket. It is much more important to be protected immediately and overcome the distrust of any vaccine rather than wanting to have another serum that is hypothetically thought to be safer and in the meantime expose yourself to the certain risk of contracting a virus “. A problem that is likely to become more serious from May 10 onwards, that is, from when the second doses will begin to be given to teachers and law enforcement officers who received the first AstraZeneca shot last February.
AstraZeneca vaccine, Mannucci hematologist: “These are the symptoms to watch out for”
by Elena Dusi
As for the supply of doses, the new EMA decision should not change plans, at least at the moment: “The practical effect on the vaccination plan is very limited because at this moment we must vaccinate people aged 70 and over as a priority. In recent days, AstraZeneca had already announced a cut of up to 50 percent of supplies in the coming weeks. For this we needed to set aside some doses to cope with the vaccination of 400 thousand over 70 years old. Now, between the stocks and the deliveries of the next two weeks, we count on having the covers on paper ”. However, the supply problem will actually arise from June, when the population aged 60 and below will have to be vaccinated.
.